低分子量肝素治疗短暂性脑缺血发作的临床及血流变研究  

Study of Clinical and Hemorrheology on Low Molecular Weight Heparin in Treatment of TIA

作　　者：朱明霞[1] 韦燕霞[1] 彭佳[1] 皮永前[1] 胡旸[1] 

机构地区：[1]柳州铁路局中心医院血液科,柳州545007

出　　处：《血栓与止血学》2004年第4期170-171,共2页Chinese Journal of Thrombosis and Hemostasis

摘　　要：目的:探讨低分子量肝素(LMWH)对短暂性脑缺血发作的疗效及血流变影响。方法:选用60例短暂性脑缺血发作的病人,其中30例为治疗组,另30例为对照组。分别观察其疗效及血流变指标等,并追踪随访1年。结果:LMWH组的有效率(93％)明显高于对照组(36.6％),对血流变指标影响明显,1年内复发率及发生永久性性脑梗死明显小于对照组。结论:LMWH治疗短暂性脑缺血发作疗效肯定,且可以改血液流变性,减少复发及发生永久性脑梗死。Objective:To investigate the clinical and hemorrheology effect of low molecular weight heparin (LMWH)in the treatment TIA. Method: 60 cases of TIA patients were studied by comparison randomly. There were 30 cases in therapy group and 30 cases in control group. Apart observe curative effect and guideline of hemorrheology etc. follow the track of one year. Result: the validity rate of therapy group was 93 % . while that of compare group was 36.6% . Guideline of hemorrheology obvious go down. Have a relapse of one year and happen permanence acute ischemic stroke was significant difference. Conclusin:LMWH in treatment of TIA is a safe effective method and may change guideline of hemorheololy. Cut down have a relapse and happen permanence cerebral infarction.

关 键 词：低分子量肝素 治疗 短暂性脑缺血发作 血流变指标 

分 类 号：R743.31[医药卫生—神经病学与精神病学]